atracurium has been researched along with methoctramine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Emala, CW; Hirshman, CA; Jooste, E; Klafter, F | 1 |
Alves-Do-Prado, W; Bando, E; Bornia, EC; Machinski, M; Pereira, MW | 1 |
2 other study(ies) available for atracurium and methoctramine
Article | Year |
---|---|
A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism.
Topics: Animals; Atracurium; Binding, Competitive; Bronchial Spasm; Cell Membrane; CHO Cells; Cricetinae; Diamines; Indicators and Reagents; Muscarinic Antagonists; Neuromuscular Nondepolarizing Agents; Piperidines; Quinuclidinyl Benzilate; Radioligand Assay; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptors, Muscarinic; Vecuronium Bromide | 2003 |
Presynaptic M1, M2, and A1 receptors play roles in tetanic fade induced by pancuronium or cisatracurium.
Topics: Animals; Atracurium; Diamines; Electric Stimulation; Hexamethonium; In Vitro Techniques; Male; Muscarinic Antagonists; Muscle Contraction; Muscle, Skeletal; Neuromuscular Nondepolarizing Agents; Nicotinic Antagonists; Pancuronium; Phrenic Nerve; Pirenzepine; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Xanthines | 2009 |